Table 3. Cox regression analysis for... | American Society of Hematology

Table 3.

Cox regression analysis for overall survival

Variable^3-150	HR	95% CI	P
T-cell depletion vs immunosuppressive medications	0.88	0.54 -1.44	.60
Age, older than 50 y vs 50 y or younger	2.07	1.32 -3.25	.002
High-risk disease vs low-risk disease	2.27	1.34 -3.85	.002
Male patient/female donor vs other combinations	1.00	0.57 -1.74	.99
HLA-mismatched vs HLA-matched	0.83	0.42 -1.63	.83
Patient CMV serologic status negative vs positive	0.70	0.45 -1.09	.70

Variable^3-150	HR	95% CI	P
T-cell depletion vs immunosuppressive medications	0.88	0.54 -1.44	.60
Age, older than 50 y vs 50 y or younger	2.07	1.32 -3.25	.002
High-risk disease vs low-risk disease	2.27	1.34 -3.85	.002
Male patient/female donor vs other combinations	1.00	0.57 -1.74	.99
HLA-mismatched vs HLA-matched	0.83	0.42 -1.63	.83
Patient CMV serologic status negative vs positive	0.70	0.45 -1.09	.70

HR indicates hazard ratio; CI, confidence interval; HLA, human leukocyte antigen; and CMV, cytomegalovirus.

F3-150

Reference groups: immunosuppressive medications, age ≤ 50 years, low-risk disease, other than male patient/female donor, HLA-matched, patient CMV serologic status positive.

View Large

This Feature Is Available To Subscribers Only